These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12857729)

  • 1. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
    Yun J; Chae HD; Choi TS; Kim EH; Bang YJ; Chung J; Choi KS; Mantovani R; Shin DY
    J Biol Chem; 2003 Sep; 278(38):36966-72. PubMed ID: 12857729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions.
    Chae HD; Yun J; Bang YJ; Shin DY
    Oncogene; 2004 May; 23(23):4084-8. PubMed ID: 15064732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
    Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
    Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-Y binds to both G1- and G2-specific cyclin promoters; a possible role in linking CDK2/Cyclin A to CDK1/Cyclin B.
    Chae HD; Kim J; Shin DY
    BMB Rep; 2011 Aug; 44(8):553-7. PubMed ID: 21871181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
    Narayanan R; Adigun AA; Edwards DP; Weigel NL
    Mol Cell Biol; 2005 Jan; 25(1):264-77. PubMed ID: 15601848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of cyclin A and cyclin kinase inhibitor p21 in response to gamma-irradiation requires the CDK2 binding region, but not the Cy motif.
    Fukuchi K; Nakamura K; Ichimura S; Tatsumi K; Gomi K
    Biochim Biophys Acta; 2003 Oct; 1642(3):163-71. PubMed ID: 14572899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
    Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
    J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.
    Habran L; Bontems S; Di Valentin E; Sadzot-Delvaux C; Piette J
    J Biol Chem; 2005 Aug; 280(32):29135-43. PubMed ID: 15955820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
    Kim WH; Kang KH; Kim MY; Choi KH
    Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
    Zhu H; Nie L; Maki CG
    J Biol Chem; 2005 Aug; 280(32):29282-8. PubMed ID: 15964852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2.
    Park CS; Kim SI; Lee MS; Youn CY; Kim DJ; Jho EH; Song WK
    J Biol Chem; 2004 May; 279(19):19592-9. PubMed ID: 14985333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
    Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
    Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation.
    Liu E; Li X; Yan F; Zhao Q; Wu X
    J Biol Chem; 2004 Apr; 279(17):17283-8. PubMed ID: 15004027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.